Document is current
Any future updates will be listed below
-
Authors
Pavlovic, Jelena M.
Vieira, Julio R.
Lipton, Richard B.
Bond, Dale S.
-
Funding
Funding for this research was provided by:
National Institutes of Health (K23AG049466)
National Institutes of Health (2PO1 AG003949)
National Institutes of Health (5U10 NS077308)
National Institutes of Health (1RO1 AG042595 (Investigator)
National Institutes of Health (RO1 NS082432)
National Institutes of Health (K23 NS09610)
National Institutes of Health (K23AG049466)
- License Information
-
More Information
Article History
First Online: 25 August 2017
Compliance with Ethical Standards
:
: Jelena M. Pavlovic declares grant support from the NIH (K23AG049466), and honoraria from Allergan and the American Headache Society for consultant work.Richard B. Lipton declares research support from the NIH: 2PO1 AG003949 (program director), 5U10 NS077308 (PI), 1RO1 AG042595 (investigator), RO1 NS082432 (investigator), K23 NS09610 (mentor), and K23AG049466 (mentor). He also receives support from the Migraine Research Foundation and the National Headache Foundation. He serves on the Editorial Board of Neurology and as senior advisor to Headache. He has reviewed for the NIA and NINDS, holds stock options in eNeura Therapeutics; serves as consultant, advisory board member, or has received honoraria from American Academy of Neurology, Alder, Allergan, American Headache Society, Amgen, Autonomic Technologies, Avanir, Biohaven, Biovision, Boston Scientific, Colucid, Dr. Reddy’s, Electrocore, Eli Lilly, eNeura Therapeutics, GlaxoSmithKlein, Merck, Pernix, Pfizer, Supernus, Teva, Trigemina, Vector, and Vedanta. He receives royalties from Wolff’s Headache, 8th Edition, Oxford Press University, 2009, Wiley and Informa.Julio R. Vieira and Dale S. Bond declare that they have no conflicts of interest.
: This article does not contain any studies with human or animal subjects performed by any of the authors.
